Crystalline retinopathy association with flupentixol intake

Area of Science:

• Ophthalmology
• Pharmacology
• Neuroscience

Background:

• Flupentixol is an antipsychotic medication used to treat depression.
• Crystalline retinopathy is a rare condition characterized by the deposition of crystals in the retina.

Observation:

• A 36-year-old female patient developed crystalline retinopathy while on long-term flupentixol treatment.
• Fundus examination revealed multiple yellowish-white refractile intraretinal deposits.
• Optical coherence tomography (OCT) confirmed the deposits in the inner retina.

Findings:

• The case suggests a potential association between chronic flupentixol use and the development of crystalline retinopathy.
• The patient had a cumulative dose of 4380 mg of flupentixol over two years.

Implications:

• Regular retinal examinations may be warranted for patients undergoing chronic flupentixol therapy.
• Further research is needed to establish a definitive causal link between flupentixol and crystalline retinopathy.